FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
EGIS-11150, 494861-87-9, EGIS-11150 Intermediate 84163-77-9, stock 558.6g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
EGIS-11150, 494861-87-9, EGIS-11150 Intermediate 82436-79-1, stock 588.5g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
EGIS-11150, 494861-87-9, EGIS-11150 Intermediate 494861-87-9, stock 160.4g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |